LGB Forge Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: September 12, 2025, 11:47 am

Quick Insight

LGB Forge Ltd, with a share price of 9.24 and a market cap of 220 Cr., exhibits concerning financial metrics, including a negative net profit of -1.22 Cr. and a high P/BV ratio of 10.60x. The company's low ROCE of 1.79% and negative ICR of 0.09x raise red flags about its operational efficiency and financial health. Additionally, the high CCC of 162.95 days indicates potential liquidity challenges. With promoters holding a significant stake of 73.79% and no FII or DII ownership, investor confidence may be impacted. LGB Forge Ltd faces significant hurdles in profitability, liquidity, and investor trust, necessitating a thorough strategic reassessment to drive sustainable growth and value creation.

Competitors of LGB Forge Ltd

All Competitor Stocks of LGB Forge Ltd

Quarterly Result

Last Updated: August 20, 2025, 7:45 am

Below is a detailed analysis of the quarterly data for LGB Forge Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 27.64 Cr.. The value appears strong and on an upward trend. It has increased from 23.93 Cr. (Mar 2025) to 27.64 Cr., marking an increase of 3.71 Cr..
• For Expenses, as of Jun 2025, the value is 25.97 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 23.10 Cr. (Mar 2025) to 25.97 Cr., marking an increase of 2.87 Cr..
• For Operating Profit, as of Jun 2025, the value is 1.67 Cr.. The value appears strong and on an upward trend. It has increased from 0.83 Cr. (Mar 2025) to 1.67 Cr., marking an increase of 0.84 Cr..
• For OPM %, as of Jun 2025, the value is 6.04%. The value appears strong and on an upward trend. It has increased from 3.47% (Mar 2025) to 6.04%, marking an increase of 2.57%.
• For Other Income, as of Jun 2025, the value is 0.82 Cr.. The value appears strong and on an upward trend. It has increased from 0.32 Cr. (Mar 2025) to 0.82 Cr., marking an increase of 0.50 Cr..
• For Interest, as of Jun 2025, the value is 0.74 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.70 Cr. (Mar 2025) to 0.74 Cr., marking an increase of 0.04 Cr..
• For Depreciation, as of Jun 2025, the value is 0.87 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.85 Cr. (Mar 2025) to 0.87 Cr., marking an increase of 0.02 Cr..
• For Profit before tax, as of Jun 2025, the value is 0.88 Cr.. The value appears strong and on an upward trend. It has increased from -0.40 Cr. (Mar 2025) to 0.88 Cr., marking an increase of 1.28 Cr..
• For Tax %, as of Jun 2025, the value is 0.00%. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00%.
• For Net Profit, as of Jun 2025, the value is 0.88 Cr.. The value appears strong and on an upward trend. It has increased from -0.40 Cr. (Mar 2025) to 0.88 Cr., marking an increase of 1.28 Cr..
• For EPS in Rs, as of Jun 2025, the value is 0.04. The value appears strong and on an upward trend. It has increased from -0.02 (Mar 2025) to 0.04, marking an increase of 0.06.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: May 15, 2025, 6:04 am

Growth

Last Updated: September 5, 2025, 9:45 am

Balance Sheet

Last Updated: May 13, 2025, 3:11 pm

Below is a detailed analysis of the balance sheet data for LGB Forge Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 23.82 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 23.82 Cr..
• For Reserves, as of Mar 2025, the value is -5.53 Cr.. The value appears to be worsening (becoming more negative). It has deteriorated from -3.65 Cr. (Mar 2024) to -5.53 Cr., marking a decline of 1.88 Cr..
• For Borrowings, as of Mar 2025, the value is 26.51 Cr.. The value appears to be improving (decreasing). However, Reserves are negative, which is a major warning sign. It has decreased from 29.74 Cr. (Mar 2024) to 26.51 Cr., marking a decrease of 3.23 Cr..
• For Other Liabilities, as of Mar 2025, the value is 17.72 Cr.. The value appears to be improving (decreasing). It has decreased from 29.06 Cr. (Mar 2024) to 17.72 Cr., marking a decrease of 11.34 Cr..
• For Total Liabilities, as of Mar 2025, the value is 62.52 Cr.. The value appears to be improving (decreasing). It has decreased from 78.97 Cr. (Mar 2024) to 62.52 Cr., marking a decrease of 16.45 Cr..
• For Fixed Assets, as of Mar 2025, the value is 17.38 Cr.. The value appears strong and on an upward trend. It has increased from 12.08 Cr. (Mar 2024) to 17.38 Cr., marking an increase of 5.30 Cr..
• For CWIP, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
• For Investments, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
• For Other Assets, as of Mar 2025, the value is 45.14 Cr.. The value appears to be declining and may need further review. It has decreased from 66.89 Cr. (Mar 2024) to 45.14 Cr., marking a decrease of 21.75 Cr..
• For Total Assets, as of Mar 2025, the value is 62.52 Cr.. The value appears to be declining and may need further review. It has decreased from 78.97 Cr. (Mar 2024) to 62.52 Cr., marking a decrease of 16.45 Cr..

However, the Borrowings (26.51 Cr.) are higher than the Reserves (-5.53 Cr.), which may signal higher financial risk.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Key Financial Ratios

After reviewing the key financial ratios for LGB Forge Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 24, the value is 1.00. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 1.00.
• For Basic EPS (Rs.), as of Mar 24, the value is -0.41. This value is below the healthy minimum of 5. It has decreased from -0.39 (Mar 23) to -0.41, marking a decrease of 0.02.
• For Diluted EPS (Rs.), as of Mar 24, the value is -0.41. This value is below the healthy minimum of 5. It has decreased from -0.39 (Mar 23) to -0.41, marking a decrease of 0.02.
• For Cash EPS (Rs.), as of Mar 24, the value is -0.29. This value is below the healthy minimum of 3. It has decreased from -0.18 (Mar 23) to -0.29, marking a decrease of 0.11.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 0.84. It has decreased from 1.27 (Mar 23) to 0.84, marking a decrease of 0.43.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 0.84. It has decreased from 1.27 (Mar 23) to 0.84, marking a decrease of 0.43.
• For Revenue From Operations / Share (Rs.), as of Mar 24, the value is 3.75. It has decreased from 4.88 (Mar 23) to 3.75, marking a decrease of 1.13.
• For PBDIT / Share (Rs.), as of Mar 24, the value is 0.01. This value is below the healthy minimum of 2. It has increased from -0.09 (Mar 23) to 0.01, marking an increase of 0.10.
• For PBIT / Share (Rs.), as of Mar 24, the value is -0.10. This value is below the healthy minimum of 0. It has increased from -0.29 (Mar 23) to -0.10, marking an increase of 0.19.
• For PBT / Share (Rs.), as of Mar 24, the value is -0.23. This value is below the healthy minimum of 0. It has increased from -0.39 (Mar 23) to -0.23, marking an increase of 0.16.
• For Net Profit / Share (Rs.), as of Mar 24, the value is -0.41. This value is below the healthy minimum of 2. It has decreased from -0.39 (Mar 23) to -0.41, marking a decrease of 0.02.
• For PBDIT Margin (%), as of Mar 24, the value is 0.34. This value is below the healthy minimum of 10. It has increased from -2.02 (Mar 23) to 0.34, marking an increase of 2.36.
• For PBIT Margin (%), as of Mar 24, the value is -2.74. This value is below the healthy minimum of 10. It has increased from -6.14 (Mar 23) to -2.74, marking an increase of 3.40.
• For PBT Margin (%), as of Mar 24, the value is -6.29. This value is below the healthy minimum of 10. It has increased from -8.00 (Mar 23) to -6.29, marking an increase of 1.71.
• For Net Profit Margin (%), as of Mar 24, the value is -11.03. This value is below the healthy minimum of 5. It has decreased from -8.00 (Mar 23) to -11.03, marking a decrease of 3.03.
• For Return on Networth / Equity (%), as of Mar 24, the value is -48.92. This value is below the healthy minimum of 15. It has decreased from -30.84 (Mar 23) to -48.92, marking a decrease of 18.08.
• For Return on Capital Employeed (%), as of Mar 24, the value is -7.17. This value is below the healthy minimum of 10. It has increased from -20.95 (Mar 23) to -7.17, marking an increase of 13.78.
• For Return On Assets (%), as of Mar 24, the value is -12.49. This value is below the healthy minimum of 5. It has decreased from -10.92 (Mar 23) to -12.49, marking a decrease of 1.57.
• For Long Term Debt / Equity (X), as of Mar 24, the value is 0.64. This value is within the healthy range. It has increased from 0.08 (Mar 23) to 0.64, marking an increase of 0.56.
• For Total Debt / Equity (X), as of Mar 24, the value is 1.44. This value exceeds the healthy maximum of 1. It has increased from 0.86 (Mar 23) to 1.44, marking an increase of 0.58.
• For Asset Turnover Ratio (%), as of Mar 24, the value is 1.09. It has decreased from 1.37 (Mar 23) to 1.09, marking a decrease of 0.28.
• For Current Ratio (X), as of Mar 24, the value is 1.46. This value is below the healthy minimum of 1.5. It has increased from 1.29 (Mar 23) to 1.46, marking an increase of 0.17.
• For Quick Ratio (X), as of Mar 24, the value is 0.83. This value is below the healthy minimum of 1. It has increased from 0.71 (Mar 23) to 0.83, marking an increase of 0.12.
• For Inventory Turnover Ratio (X), as of Mar 24, the value is 1.45. This value is below the healthy minimum of 4. It has decreased from 2.22 (Mar 23) to 1.45, marking a decrease of 0.77.
• For Interest Coverage Ratio (X), as of Mar 24, the value is 0.09. This value is below the healthy minimum of 3. It has increased from -1.09 (Mar 23) to 0.09, marking an increase of 1.18.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 24, the value is -0.77. This value is below the healthy minimum of 3. It has increased from -3.30 (Mar 23) to -0.77, marking an increase of 2.53.
• For Enterprise Value (Cr.), as of Mar 24, the value is 242.24. It has increased from 224.14 (Mar 23) to 242.24, marking an increase of 18.10.
• For EV / Net Operating Revenue (X), as of Mar 24, the value is 2.71. This value is within the healthy range. It has increased from 1.93 (Mar 23) to 2.71, marking an increase of 0.78.
• For EV / EBITDA (X), as of Mar 24, the value is 776.92. This value exceeds the healthy maximum of 15. It has increased from -95.39 (Mar 23) to 776.92, marking an increase of 872.31.
• For MarketCap / Net Operating Revenue (X), as of Mar 24, the value is 2.39. This value is within the healthy range. It has increased from 1.71 (Mar 23) to 2.39, marking an increase of 0.68.
• For Price / BV (X), as of Mar 24, the value is 10.60. This value exceeds the healthy maximum of 3. It has increased from 6.58 (Mar 23) to 10.60, marking an increase of 4.02.
• For Price / Net Operating Revenue (X), as of Mar 24, the value is 2.39. This value is within the healthy range. It has increased from 1.71 (Mar 23) to 2.39, marking an increase of 0.68.
• For EarningsYield, as of Mar 24, the value is -0.04. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 23) which recorded -0.04.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness